12934819

Source:http://linkedlifedata.com/resource/pubmed/id/12934819

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0030705, umls-concept:C0031809, umls-concept:C0035647, umls-concept:C0035648, umls-concept:C0205251, umls-concept:C0205314, umls-concept:C0441471, umls-concept:C0679622, umls-concept:C1514983, umls-concept:C1527178, umls-concept:C1705938
pubmed:issue	4
pubmed:dateCreated	2003-8-25
pubmed:abstractText	Coronary heart disease (CHD) risk assessed by the Framingham risk score does not take into account the various "novel" markers that are of increasing interest. In this paper we examine a low-risk population to determine which novel markers may be of additive value to the Framingham assessment of CHD risk.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7804071
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin, http://linkedlifedata.com/resource/pubmed/chemical/Homocysteine, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Cell Adhesion Molecule-1, http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0147-958X
pubmed:author	pubmed-author:ChanSammyS, pubmed-author:FrohlichJiriJ, pubmed-author:GrewalJasmineJ, pubmed-author:ManciniG B JohnGB
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	158-65
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:12934819-Adult, pubmed-meshheading:12934819-Aged, pubmed-meshheading:12934819-Biological Markers, pubmed-meshheading:12934819-C-Reactive Protein, pubmed-meshheading:12934819-Cardiovascular Diseases, pubmed-meshheading:12934819-Cohort Studies, pubmed-meshheading:12934819-E-Selectin, pubmed-meshheading:12934819-Female, pubmed-meshheading:12934819-Homocysteine, pubmed-meshheading:12934819-Humans, pubmed-meshheading:12934819-Inflammation, pubmed-meshheading:12934819-Intercellular Adhesion Molecule-1, pubmed-meshheading:12934819-Male, pubmed-meshheading:12934819-Middle Aged, pubmed-meshheading:12934819-Multivariate Analysis, pubmed-meshheading:12934819-Regression Analysis, pubmed-meshheading:12934819-Risk Factors, pubmed-meshheading:12934819-Time Factors, pubmed-meshheading:12934819-Vascular Cell Adhesion Molecule-1, pubmed-meshheading:12934819-von Willebrand Factor
pubmed:year	2003
pubmed:articleTitle	Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification.
pubmed:affiliation	Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC.
pubmed:publicationType	Journal Article